Omicron’s Explosive Growth is a Warning Sign
The Atlantic contributor Sarah Zhang discusses the rapidly spreading Omicron variant and how uncertainty surrounding the variant presents serious dangers. She also covers the tools the health community has to fight Omicron.
- How aggressive should the U.S. and global community be in responding to Omicron?
Omicron can hit fully vaccinated, Oxford study says, as UK prepares for tidal wave of cases
Scientists have found that two doses of the Oxford-AstraZeneca or Pfizer-BioNTech Covid-19 vaccines are substantially less effective at warding off Omicron than previous variants of the coronavirus.
- Do you think it will be easy to convince people to get a booster shot?
Tracking Omicron and Other Coronavirus Variants
This article includes a world map tracking Omicron.
- Why do you think this variant is more transmissible than variants like Iota?
Omicron Variant Arrives in United States
The cohosts of The View discuss the confirmation of an Omicron case in the United States. They argue that the Trump Administration is responsible for politicizing the virus and its failed response to Covid-19.
- Who are some of the actors ultimately responsible for the current state of Covid-19? Why do you think so?
WEBINAR | Military Vaccine Mandates: a National Security Catastrophe
The list of people who have suffered serious adverse effects, likely from the vaccine, continues to grow on the government’s own voluntary Vaccine Adverse Event Reporting System (VAERS). Victims who believe the vaccines injured them are routinely ignored, censored, and accused of spreading misinformation by the very institutions and agencies tasked with investigating their claims. Expert panelists discuss how mandates pose catastrophic risks to U.S. service members, military readiness, and national security.
- Should vaccine mandates still be implemented for low-risk individuals?
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Among patients in a large Israeli health care system who had received at least one dose of the BNT162b2 mRNA vaccine, the estimated incidence of myocarditis was 2.13 cases per 100,000 persons; the highest incidence was among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate in severity.
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults
Conclusions: Most cases of suspected COVID-19 vaccine myocarditis occurring in persons <21 years have a mild clinical course with rapid resolution of symptoms. Abnormal findings on cMRI were frequent. Future studies should evaluate risk factors, mechanisms, and long-term outcomes.
Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
Our study suggests that myocarditis adverse events are linked to vaccine type, technology, age, and sex of the vaccinated individuals. Based on VAERS data, post-vaccine myocarditis was most frequently reported for live vaccines, or vaccines that behave like live vaccines such as mRNA and possibly viral vector vaccines versus inactivated vaccines. This approach can be applied for conducting similar analyses involving other side effects or other vaccines. Hence, our workflow stands ready for following up on an alarming report from the CDC.